Alendronate may lower cardiovascular risk in hip fracture patients
Study finds a treatment for osteoporosis may reduce the risk of cardiovascular events in people with hip fractures.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Orthopaedics | Osteoporosis | Study